09-025
Showing 1 - 25 of 1,460
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Asthma, COPD Trial in Amsterdam, Groningen (FP-025 capsules, Placebo FP-025 capsules)
Recruiting
- Asthma, COPD
- FP-025 capsules
- Placebo FP-025 capsules
-
Amsterdam, Netherlands
- +1 more
Apr 19, 2022
Hypercholesterolemia Trial (MK0653, ezetimibe / Duration of Treatment: 28 weeks, Comparator: atorvastatin / Duration of
Completed
- Hypercholesterolemia
- MK0653, ezetimibe / Duration of Treatment: 28 weeks
- Comparator: atorvastatin / Duration of Treatment: 28 weeks
- (no location specified)
Feb 4, 2022
Genito-Pelvic Pain/Penetration Disorder Trial in Lahore (soft tissue release, vaginal dilators)
Recruiting
- Genito-Pelvic Pain/Penetration Disorder
- soft tissue release
- vaginal dilators
-
Lahore, Punjab, PakistanLahore general hospital
May 4, 2023
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Glabellar Frown Lines Trial in Miami (AI-09, Vehicle)
Recruiting
- Glabellar Frown Lines
- AI-09
- Vehicle
-
Miami, FloridaBaumann Cosmetic & Research Institute
Oct 11, 2022
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)
Not yet recruiting
- Melanoma
- +16 more
-
Darlinghurst, New South Wales, Australia
- +3 more
May 12, 2023
Healthy Participants Trial in Fukuoka (Road-tracking test, Car-following test, Harsh-braking test)
Completed
- Healthy Participants
- Road-tracking test
- +2 more
-
Fukuoka, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Severe to Critical COVID 19 With Associated ARDS Trial in United States (FP-025 100 mg, FP-025 300 mg, Placebo)
Terminated
- Severe to Critical COVID 19 With Associated ARDS
- FP-025 100 mg
- +2 more
-
Chula Vista, California
- +7 more
Aug 4, 2022
Malignant Gastric Outlet Obstruction Trial (Surgical gastrojejunostomy (S-GJ), EUS-guided gastrojejunostomy (EUS-GJ))
Not yet recruiting
- Malignant Gastric Outlet Obstruction
- Surgical gastrojejunostomy (S-GJ)
- EUS-guided gastrojejunostomy (EUS-GJ)
- (no location specified)
Nov 9, 2023
Epithelial Lining Fluid and Blood Pharmacokinetics and
Recruiting
- Polymyxin B
- +3 more
- nebulized polymyxin B
-
Nanjing, Jiangsu, ChinaZhongda Hospital Affiliated to Southeast University
Oct 7, 2023
Advanced Solid Tumor Trial (EMB-09)
Not yet recruiting
- Advanced Solid Tumor
- EMB-09
- (no location specified)
Feb 22, 2022
Tinnitus, Tinnitus, Subjective Trial in Zurich (transcranial Random Noise Stimulation (tRNS) with acoustic stimulation (AS),
Recruiting
- Tinnitus
- Tinnitus, Subjective
- transcranial Random Noise Stimulation (tRNS) with acoustic stimulation (AS)
- transcranial Random Noise Stimulation (tRNS) without acoustic stimulation (AS)
-
Zurich, SwitzerlandUniversity Hospital Zurich, University Zurich
Nov 21, 2022
Post Operative Pain, Laparoscopic Surgery, Pediatrics Trial in Ankara (M-TAPA Block, Local anesthetic infltration to port sites)
Enrolling by invitation
- Post Operative Pain
- +4 more
- M-TAPA Block
- Local anesthetic infltration to port sites
-
Ankara, Kecioren, TurkeyGulhane Training and Research Hospital
Sep 8, 2023
HER2-positive Breast Cancer Trial in Uppsala (ABY-PET)
Recruiting
- HER2-positive Breast Cancer
- ABY-PET
-
Uppsala, SwedenSection for Clinical Research & Development Unit
Sep 28, 2021
Fatigue Severity Scale in Patients With Fibromyalgia
Recruiting
- Fibromyalgia
-
Lahore, Punjab, PakistanUniversity of Lahore Teaching Hospital
Sep 3, 2023
Multimodal CT Examination in Stroke Mimics Diagnosis
Not yet recruiting
- Stroke Mimics
- Multimodal brain CT
- Magnetic resonance imaging (MRI)
-
Ostrava, Moravian-Silesian Region, Czechia
- +2 more
Sep 19, 2023
Long Term Follow-up on Menkes Disease Patients
Enrolling by invitation
- Menkes Disease
- Long Term Follow-Up
-
New York, New YorkCyprium Study Team
Jul 14, 2022
Esophageal Tumors, Gastric Tumors Malignant, Breast Cancer Trial in Stockholm ([68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2
Recruiting
- Esophageal Neoplasms
- +3 more
- [68Ga]Ga-ABY-025 PET
- Biopsy and analysis of HER2 expression
-
Stockholm, SwedenDepartment of Radiation Physics and Nuclear Medicine, Karolinska
Nov 25, 2022